Imatinib Standard Dose (400 mg/Day) Versus Imatinib High Dose (800 mg/Day)
NCT00514488
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
OTHER
Sponsor class
Conditions
Chronic Myeloid Leukemia
Interventions
DRUG:
STI571 (400 mg/day; or 800 mg/day)
Sponsor
University of Bologna
Collaborators
[object Object]